Oxymorphone Hydrochloride Patent Expiration
Oxymorphone Hydrochloride is Used for managing moderate to severe pain. It was first introduced by Endo Pharmaceuticals Inc
Oxymorphone Hydrochloride Patents
Given below is the list of patents protecting Oxymorphone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Opana Er | US8871779 | Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds | Nov 22, 2029 | Endo Operations |
| Opana Er | US8871779 | Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds | Nov 22, 2029 | Endo Pharms |
| Opana Er | US7851482 | Method for making analgesics | Jul 10, 2029 | Endo Pharms |
| Opana Er | US8808737 | Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment | Jun 21, 2027 | Endo Operations |
| Opana Er | US8808737 | Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment | Jun 21, 2027 | Endo Pharms |
| Opana Er | US8192722 | Abuse-proof dosage form | Sep 15, 2025 | Endo Pharms |
| Opana Er | US8114383 | Abuse-proofed dosage form |
Aug 08, 2024
(Expired) | Endo Pharms |
| Opana Er | US8075872 | Abuse-proofed dosage form |
Nov 20, 2023
(Expired) | Endo Pharms |
| Opana Er | US8309060 | Abuse-proofed dosage form |
Nov 20, 2023
(Expired) | Endo Pharms |
| Opana Er | US7276250 | Sustained release formulations of oxymorphone |
Feb 04, 2023
(Expired) | Endo Operations |
| Opana Er | US8309112 | Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same |
Feb 04, 2023
(Expired) | Endo Operations |
| Opana Er | US8309122 | Oxymorphone controlled release formulations |
Feb 04, 2023
(Expired) | Endo Pharms |
| Opana Er | US8329216 | Oxymorphone controlled release formulations |
Feb 04, 2023
(Expired) | Endo Operations |
| Opana Er | US8329216 | Oxymorphone controlled release formulations |
Feb 04, 2023
(Expired) | Endo Pharms |
| Opana Er | US5662933 | Controlled release formulation (albuterol) |
Sep 09, 2013
(Expired) | Endo Operations |
| Opana Er | US5958456 | Controlled release formulation (albuterol) |
Sep 09, 2013
(Expired) | Endo Operations |
Oxymorphone Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Oxymorphone Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Oxymorphone Hydrochloride. The first generic version for Oxymorphone Hydrochloride was by Impax Laboratories Inc and was approved on Jun 14, 2010. And the latest generic version is by Ascent Pharmaceuticals Inc and was approved on Feb 2, 2018.
Given below is the list of companies who have filed for Oxymorphone Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS ELIZABETH
Actavis Elizabeth Llc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Oxymorphone Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet, extended release | Discontinued | ORAL | N/A | Dec 13, 2010 |
| 15MG | tablet, extended release | Discontinued | ORAL | N/A | Dec 13, 2010 |
| 10MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 11, 2013 |
| 40MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 11, 2013 |
| 20MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 11, 2013 |
| 5MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 11, 2013 |
| 30MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 11, 2013 |
Manufacturing Plant Locations New
Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
2. ASCENT PHARMS INC
Ascent Pharmaceuticals Inc has filed for 2 different strengths of generic version for Oxymorphone Hydrochloride. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Feb 2, 2018 |
| 5MG | tablet | Prescription | ORAL | AB | Feb 2, 2018 |
3. AUROLIFE PHARMA LLC
Aurolife Pharma Llc has filed for 2 different strengths of generic version for Oxymorphone Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurolife Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Apr 26, 2016 |
| 5MG | tablet | Prescription | ORAL | AB | Apr 26, 2016 |
Manufacturing Plant Locations New
Aurolife Pharma Llc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Aurolife Pharma Llc as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
4. AVANTHI INC
Avanthi Inc has filed for 2 different strengths of generic version for Oxymorphone Hydrochloride. Given below are the details of the strengths of this generic introduced by Avanthi Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Jan 30, 2013 |
| 10MG
(reference standard) | tablet | Prescription | ORAL | AB | Jan 30, 2013 |
5. EPIC PHARMA LLC
Epic Pharma Llc has filed for 2 different strengths of generic version for Oxymorphone Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Dec 15, 2014 |
| 5MG | tablet | Prescription | ORAL | AB | Dec 15, 2014 |
6. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Oxymorphone Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 15, 2013 |
| 5MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 15, 2013 |
| 20MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 15, 2013 |
| 40MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 15, 2013 |
| 7.5MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 15, 2013 |
| 15MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 15, 2013 |
| 30MG | tablet, extended release | Discontinued | ORAL | N/A | Jul 15, 2013 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
7. IMPAX LABS
Impax Laboratories Inc has filed for 7 different strengths of generic version for Oxymorphone Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet, extended release | Prescription | ORAL | N/A | Jun 14, 2010 |
| 40MG
(reference standard) | tablet, extended release | Prescription | ORAL | N/A | Jun 14, 2010 |
| 20MG | tablet, extended release | Prescription | ORAL | N/A | Jun 14, 2010 |
| 5MG | tablet, extended release | Prescription | ORAL | N/A | Jun 14, 2010 |
| 30MG | tablet, extended release | Prescription | ORAL | N/A | Jul 22, 2010 |
| 15MG | tablet, extended release | Prescription | ORAL | N/A | Dec 21, 2010 |
| 7.5MG | tablet, extended release | Prescription | ORAL | N/A | Dec 21, 2010 |
8. PAR PHARM
Par Pharmaceutical Inc has filed for 7 different strengths of generic version for Oxymorphone Hydrochloride. Given below are the details of the strengths of this generic introduced by Par Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 24, 2014 |
| 10MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 24, 2014 |
| 40MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 24, 2014 |
| 30MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 24, 2014 |
| 20MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 24, 2014 |
| 15MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 24, 2014 |
| 5MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 24, 2014 |
Manufacturing Plant Locations New
Par Pharm's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Par Pharm as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
9. SPECGX LLC
Specgx Llc has filed for 7 different strengths of generic version for Oxymorphone Hydrochloride. Given below are the details of the strengths of this generic introduced by Specgx Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet, extended release | Discontinued | ORAL | N/A | Jun 27, 2014 |
| 5MG | tablet, extended release | Discontinued | ORAL | N/A | Jun 27, 2014 |
| 7.5MG | tablet, extended release | Discontinued | ORAL | N/A | Jun 27, 2014 |
| 30MG | tablet, extended release | Discontinued | ORAL | N/A | Jun 27, 2014 |
| 20MG | tablet, extended release | Discontinued | ORAL | N/A | Jun 27, 2014 |
| 15MG | tablet, extended release | Discontinued | ORAL | N/A | Jun 27, 2014 |
| 40MG | tablet, extended release | Discontinued | ORAL | N/A | Jun 27, 2014 |
Manufacturing Plant Locations New
Specgx Llc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Specgx Llc as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||
10. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 7 different strengths of generic version for Oxymorphone Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet, extended release | Discontinued | ORAL | N/A | Apr 24, 2015 |
| 15MG | tablet, extended release | Discontinued | ORAL | N/A | Apr 24, 2015 |
| 20MG | tablet, extended release | Discontinued | ORAL | N/A | Apr 24, 2015 |
| 30MG | tablet, extended release | Discontinued | ORAL | N/A | Apr 24, 2015 |
| 40MG | tablet, extended release | Discontinued | ORAL | N/A | Apr 24, 2015 |
| 5MG | tablet, extended release | Discontinued | ORAL | N/A | Apr 24, 2015 |
| 7.5MG | tablet, extended release | Discontinued | ORAL | N/A | Apr 24, 2015 |
11. TEVA
Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Oxymorphone Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Feb 15, 2011 |
| 10MG | tablet | Prescription | ORAL | AB | Feb 15, 2011 |
Manufacturing Plant Locations New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| India |
| |||||||||
| Canada |
| |||||||||
| Czech Republic |
| |||||||||
| Ireland |
| |||||||||
| Israel |
| |||||||||